États-Unis · Bourse & Finance · Yahoo Finance

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Publié par Yahoo Finance · États-Unis il y a 8 h

ORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market Orion…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

À lire aussi

What is Beam? The buzzy American AI model being called the 'DeepSeek of the West'

South Korea Investigates Possible Use of A.I. in Hacks on Its Banks

Here’s what happened in crypto today

How quant funds beat the market by being 'early, contrarian and right'

U.S. scraps proposed $10,000 reporting rule for for crypto sent to private wallets

OKX debuts a platform that turns 50 currencies into digital dollars, betting emerging market investors want stablecoins

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Partager

À lire aussi

What is Beam? The buzzy American AI model being called the 'DeepSeek of the West'

South Korea Investigates Possible Use of A.I. in Hacks on Its Banks

Here’s what happened in crypto today

How quant funds beat the market by being 'early, contrarian and right'

U.S. scraps proposed $10,000 reporting rule for for crypto sent to private wallets

OKX debuts a platform that turns 50 currencies into digital dollars, betting emerging market investors want stablecoins